Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
NASDAQ
16.302,76
-0,18%
Bitcoin
61.189,59
-1,84%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Medicenna Therapeutics Corporation (MDNA) Medicenna Therapeutics Corporation (MDNA) Notizie

Medicenna Therapeutics Corporation

MDNA
0,157
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202421:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/4/202421:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/4/202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/4/202422:40EDGAR2Form AW - Amendment Withdrawal Request
16/4/202423:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
16/4/202423:05EDGAR2Form F-3/A - Registration statement by foreign private..
16/4/202423:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
09/4/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/4/202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202416:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202415:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202320:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202314:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
08/11/202316:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202313:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03/11/202317:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202313:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25/10/202321:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202313:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202313:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202313:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202314:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202313:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03/10/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202313:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28/9/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202323:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/9/202316:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202313:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/9/202313:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202313:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28/8/202322:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202322:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14/8/202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202313:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
09/8/202323:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202315:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202313:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/8/202314:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/8/202313:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01/8/202318:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202315:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/7/202314:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202313:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202313:00GLOBEMedicenna Presents at National Brain Tumor Society's..
06/7/202316:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: Min: Max:
Chiusura: 0,157

La tua Cronologia

NASDAQ
MDNA
Medicenna Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network